CommercialCoverageMedium impact
Pharmacy coverage added for Freestyle Libre for commercial members
Blue Cross Blue Shield of Rhode Island·RI · Endocrinology, Family Medicine, Internal Medicine +1 more·Physician
Effective date
May 1, 2019
We identified it
Jun 20, 2026
Summary
Abbott Freestyle Libre System (glucose monitoring device) is now covered under pharmacy benefits for commercial members who are insulin users. The system requires separate prescriptions for the reader and 14-day sensor kits, with coverage limited to 2 sensors per 28-day supply.
Action Required
Immediately: Billing team must update prior authorization processes to verify insulin use through 120-day claims lookback before approving Freestyle Libre prescriptions. Providers should write separate prescriptions for Libre reader and sensor kits. Update encounter forms to note non-preferred brand copay tier applies.